Medical Analysis

Comprehensive Medical Analysis of Dexamethasone Suppression Test for Cortisol

Introduction and Clinical Purpose of the Dexamethasone Suppression Test

The dexamethasone suppression test evaluates whether cortisol secretion by the adrenal gland can be suppressed [1, 5]. Specifically, the dexamethasone suppression test measures the response of the adrenal glands to ACTH [5]. The expected response involves cortisol levels decreasing in response to the administration of dexamethasone by a negative feedback mechanism [1, 5]. The agent utilized, dexamethasone, functions as a synthetic glucocorticoid [1]. Ultimately, this clinical evaluation assesses hypothalamic-pituitary-adrenal axis integrity [1, 2].

Primary Indications for Diagnostic Assessment

The diagnostic application of this protocol targets several pathologies [2]. Cushing syndrome represents a primary target for investigation [1, 2]. Additional applications include identifying primary adrenal insufficiency and secondary adrenal insufficiency [3]. It also enables the differentiation of pituitary versus ectopic ACTH production, facilitates the evaluation of adrenal autonomy, and assists in the assessment of depression-related cortisol evaluation [2, 4].

Clinical Contraindications and Safety Considerations

Several strict contraindications govern the administration of this test [3]. Hypersensitivity to dexamethasone or other corticosteroids prohibits its use [2, 3]. Serious infections, particularly active systemic infections requiring immunosuppression, present a barrier because corticosteroids can exacerbate infections [2, 3]. Severe mental health conditions require caution, as individuals with severe psychiatric disorders may experience worsening of their symptoms due to corticosteroid effects [3]. Uncontrolled diabetes necessitates caution since corticosteroids can increase blood glucose levels [2, 3]. Recent surgery or trauma may also render the test inappropriate, particularly if healing is a primary clinical concern [3].

Precautions to be Taken During Administration

Clinical vigilance is required under specific physiological conditions [3]. Regarding pregnancy and breastfeeding, while the test may not be strictly contraindicated, it should be used with caution and strictly under medical supervision [3]. Furthermore, regarding other medications, certain drugs such as alternative corticosteroids may interfere significantly with the final results of the test [2, 6].

Methodological Classification and Types of Tests

Protocol Execution Details for Low-Dose and High-Dose Overnight Tests

For the low-dose overnight test, baseline cortisol is measured in an early morning sample [9]. Subsequently, the patient is administered 1 mg of dexamethasone orally at 11 p.m [9]. A blood sample is then collected the next morning at 8 a.m. for a cortisol measurement [9]. Similarly, for the high-dose overnight test, baseline cortisol is measured in an early morning sample, followed by the administration of 8 mg of dexamethasone orally at 11 p.m [4]. A blood sample is subsequently collected the next morning at 8 a.m. for cortisol measurement [4].

Laboratory Analytical Methods

The primary analytical methodology relies upon the Electrochemiluminescence Immunoassay [14].

Specimen Sample Collection and Handling Protocols

Blood collection requires obtaining 3 ml of blood in a plain tube (Red capped), Lithium heparin (Green capped), or EDTA (Lavender capped) [14]. Specimen preparation dictates allowing the specimen to clot completely at room temperature, followed by separating serum or plasma from cells as early as possible or within 2 hours of blood collection [14]. Storage and transport temperature must be refrigerated [14]. Stability parameters after cell separation dictate that samples remain viable ambient for 24 hours, refrigerated for 4 days, and frozen for 12 months, while avoiding repeated freezing and thawing cycles [14].

Specialized Procedures: Intravenous Dexamethasone and Dexamethasone-CRH Tests

The intravenous dexamethasone test is indicated when oral medication compliance or absorption is uncertain [6]. The first baseline blood sample is drawn at 8 to 9 a.m. for baseline serum cortisol [6]. An intravenous infusion of dexamethasone at 1 mg per hour is administered continuously over 4 to 7 hours [6]. Serum cortisol is measured immediately at the end of the infusion on day 1 and again 23 to 24 hours later on day 2 [6]. Adequate suppression of cortisol suggests intact hypothalamic-pituitary-adrenal axis regulation, whereas failure to suppress indicates hypercortisolism and assists in differentiating ACTH-dependent causes of Cushing syndrome [6].

The dexamethasone-CRH test is carried out to differentiate between pituitary and ectopic causes of ACTH-dependent Cushing syndrome [7]. Dexamethasone is administered every six hours, usually 0.5 mg every 6 hours for 48 hours [7]. Two hours after the last dose of dexamethasone, an intravenous CRH dose of 1 mcg per kg is given, and serum cortisol is measured 15 minutes later [7]. In Cushing disease of pituitary origin, CRH causes an increase in ACTH and cortisol levels, whereas in ectopic ACTH syndrome, there is little or no response, helping establish the source of excess ACTH and guiding management [7].

Comprehensive Interpretation of Results

Established Reference Ranges and Diagnostic Cutoffs

Pathophysiological Causes of Altered Cortisol Levels

Causes of increased levels encompass congenital adrenal hyperplasia, a tumor of the adrenal gland whether benign or cancerous, and polycystic ovary syndrome (PCOS) [14]. Conversely, causes of decreased levels include Addison’s disease and hypopituitarism [14].

Interfering Factors: False Positives, False Negatives, and Interfering Drugs

Interfering drugs include anti-seizure medicines, barbiturates, medicines containing steroids like hydrocortisone and prednisone, estrogen, oral contraceptives, and diuretics [11, 14]. False-positive test results can be triggered by stress, weight loss, alcohol withdrawal, and treatment with drugs like diphenylhydantoin, phenobarbital, rifampicin, carbamazepine, and lithium [11, 14]. False-negative test results are associated with liver disease, benzodiazepines, methadone, ketoconazole, and indomethacin [11, 14].

For Non-Medicos

What Is the Dexamethasone Suppression Test and Why Is It Done?

The dexamethasone suppression test is a medical procedure used to see how well your adrenal glands make cortisol and whether your body’s natural hormone control center is working normally [1, 5]. Doctors use this test primarily to check for conditions like Cushing syndrome, where the body produces too much cortisol, as well as to investigate adrenal fatigue or underactivity, check for adrenal tumors, and evaluate stress-related hormone variations [1, 2, 14].

Who Should Avoid This Test and Important Precautions

You should not take this test if you have a known allergy to dexamethasone or other steroids, if you are fighting a serious active infection, if you suffer from severe psychiatric conditions that could worsen with steroids, if you have poorly controlled diabetes that could spike from steroid exposure, or if you are recovering from recent surgery or trauma [2, 3]. If you are pregnant or breastfeeding, the test can still be performed, but only under close medical monitoring [3]. Additionally, certain medications like other steroid drugs can alter your test scores [2, 6].

Common Variations of the Test and Preparation

Doctors use different versions of this test depending on your symptoms [2, 6, 7]. The low-dose overnight test involves taking a 1 mg pill of dexamethasone at 11 p.m. and checking your blood cortisol levels the next morning at 8 a.m [9]. The high-dose test uses an 8 mg dose to help pinpoint where an excess hormone issue originates [2, 4]. Other specialized variations include continuous intravenous infusion tests and combined dexamethasone-CRH tests, which help doctors differentiate true disease from other non-disease mimics [6, 7].

Understanding Your Results and Potential Causes

Normally, giving your body a synthetic steroid like dexamethasone should cause your natural cortisol levels to drop significantly through a built-in feedback loop [1, 5]. If your cortisol fails to drop, it often points toward conditions like pituitary tumors, adrenal growths, or ectopic hormone-producing issues [2, 4]. High cortisol levels can also be caused by congenital adrenal hyperplasia or polycystic ovary syndrome (PCOS) [14]. Low cortisol levels can point toward Addison’s disease or hypopituitarism [14].

Factors That Can Cause False Results

Several everyday factors and substances can throw off your test results, causing false alarms or missed diagnoses [11, 14]. False positives can happen due to high stress, rapid weight loss, alcohol withdrawal, or medications like barbiturates, seizure medications, rifampicin, and lithium [11, 14]. On the other hand, false negatives can be triggered by liver disease, benzodiazepines, methadone, ketoconazole, or indomethacin [11, 14]. Always share a complete list of your medications and lifestyle habits with your doctor before testing [14].

References:

1. Liddle, G.W. (1960). Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. The Journal of Clinical Endocrinology & Metabolism, 20(12), 1539–1560.

2. Nieman, L.K., Biller, B.M., Findling, J.W., Newell-Price, J., Savage, M.O., Stewart, P.M., & Montori, V.M. (2008). The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1526–1540.

3. Arnaldi, G., Angeli, A., Atkinson, A.B., Bertagna, X., Cavagnini, F., Chanson, P., Fahlbusch, R., Scavo, D., Sonino, N., Stratakis, C.A., Trainer, P.J., & Lamberts, S.W. (2003). Diagnosis and complications of Cushing’s syndrome: a consensus statement. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5593–5602.

4. Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998). A diagnostic and therapeutic algorithm for Cushing’s syndrome. The Journal of Clinical Endocrinology & Metabolism, 83(5), 1446–1456.

5. Findling, J.W., & Raff, H. (2006). Diagnosis and differential diagnosis of Cushing’s syndrome. Endocrinology and Metabolism Clinics of North America, 35(2), 374–393.

6. Meikle, A.W. (1982). Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clinical Endocrinology, 16(4), 401–408.

7. Yanovski, J.A., Cutler, G.B., Jr., Doppman, J.L., & Nieman, L.K. (1998). The diagnostic evaluation of Cushing’s syndrome: use of the desmopressin and combined dexamethasone-desmopressin tests. Pituitary, 1(1), 29–38.

8. Pecori Giraldi, F., Ambrogio, A.G., De Martin, M., & Cavagnini, F. (2007). Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. The Journal of Clinical Endocrinology & Metabolism, 92(11), 4123–4129.

9. Cron, C.J., & Raff, H. (2010). Measurement of serum cortisol and dexamethasone during the low-dose dexamethasone suppression test in clinical practice. Hormone and Metabolic Research, 42(9), 675–679.

10. Biller, B.M., Grossman, A.B., Stewart, P.M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A.R., Hofland, L.J., Klibanski, A., Lacroix, A., Lindsay, J.R., Newell-Price, J., Nieman, L.K., Petersenn, S., Sonino, N., Stalla, G.K., Swearingen, B., Vance, M.L., Wass, J.A., Boscaro, M., & Chanson, P. (2008). Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. The Journal of Clinical Endocrinology & Metabolism, 93(7), 2454–2462.

     

     

11. Kaye, T.B., & Crapo, L. (1990). The false positive dexamethasone suppression test: a review of causes and implications. The American Journal of Medicine, 89(4), 519–525.

12. Ünlütürk, U., Babaoglu, M., Bayraktar, M., & Çakir, B. (2014). The evaluation of mild autonomous cortisol secretion in adrenal incidentalomas: a critical review of the dexamethasone suppression test cut-offs. European Journal of Endocrinology, 171(4), R133–R148.

13. Reimondo, G., Pia, A., & Angeli, A. (2008). Diagnostic evaluation of adrenal incidentalomas. Best Practice & Research Clinical Endocrinology & Metabolism, 22(1), 107–119.

14. Dogra, P., & Mazza, J. (2024). Dexamethasone Suppression Test. StatPearls Publishing, Treasure Island (FL).

FAQ’s:

• What does the test measure?
  It measures whether cortisol secretion by the adrenal gland can be suppressed.
• What is the primary test indication?
  It is primarily used to diagnose Cushing syndrome and evaluate HPA axis integrity.
• Are there any test contraindications?
  Yes, including hypersensitivity to corticosteroids, active serious infections, and severe mental health conditions.
• How is the low-dose test performed?
  Patients take 1 mg of oral dexamethasone at 11 p.m. for morning cortisol measurement.
• What is the high-dose test purpose?
  It helps differentiate pituitary sources from ectopic ACTH secretion.
• Which analytical method is used? Electrochemiluminescence Immunoassay is the primary method used for analysis.
• How should blood samples be stored?
  Samples must be refrigerated and remain stable for up to 4 days.
• What indicates a normal suppression result?
  Serum cortisol levels falling below 1.8 micrograms per deciliter after a low dose.
• What causes decreased cortisol levels?
  Conditions such as Addison’s disease and hypopituitarism lead to decreased levels.
• Can medications interfere with results?
  Yes, alternative corticosteroids, anti-seizure drugs, and oral contraceptives can interfere with test results.
  

Related Tests

• Adrenocorticotropic Hormone (ACTH) Blood Test
• Corticotropin-Releasing Hormone (CRH) Stimulation Test